What is Rapid Micro Biosystems's D&A?

Rapid Micro Biosystems (RPID) reported D&A of $706K in Q1 2026.

How has Rapid Micro Biosystems's D&A changed year-over-year?

Rapid Micro Biosystems's D&A decreased by 16.6% year-over-year, from $847K to $706K.

What is the long-term trend for Rapid Micro Biosystems's D&A?

Over 4 years (2021 to 2025), Rapid Micro Biosystems's D&A has grown at a 21.5% compound annual growth rate (CAGR), from $1.49M to $3.25M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Rapid Micro Biosystems RPID D&A

D&A at other companies

Charles River LaboratoriesCRL

$67.15M-44.2%

Pacific Biosciences of CaliforniaPACB

$2.2M-57.1%

iRadimedIRMD

$455K+135%

Ginkgo BioworksDNA

$12.8M-13.6%

West Pharmaceutical ServicesWST

$44.6M+14.1%

Lifecore Biomedical, Inc.LFCR

$2.31M+20.7%

Other financials

Income statement

See full

Revenue$8.0M+11.1%

Gross profit$371.0K-8.2%

Operating income-$13.9M-18.8%

Net income-$14.3M-26.7%

EPS (diluted)-$0.31-19.2%

Balance sheet

See full

Cash & equivalents$14.1M-26.8%

Total debt$23.8M+301%

Total equity$20.4M-68.9%

Total assets$62.4M-27.0%

Cash flow

See full

Operating cash flow-$15.1M-66.1%

CapEx$394.0K+23.5%

Free cash flow-$15.5M-64.7%

Valuation

See full

Market cap$86.19M-43.8%

Enterprise value$95.86M-31.7%

P/S2.5×-2.6×

Profitability

See full

Operating margin-144.2%-12.7pp

Net margin-145.8%-5.0pp

FCF margin-110.5%-14.9pp

Returns & leverage

See full

Return on equity-116.7%-620pp

Debt / equity1.2×+1.1×

Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapid Micro Biosystems's D&A?: Rapid Micro Biosystems (RPID) reported D&A of $706K in Q1 2026.
How has Rapid Micro Biosystems's D&A changed year-over-year?: Rapid Micro Biosystems's D&A decreased by 16.6% year-over-year, from $847K to $706K.
What is the long-term trend for Rapid Micro Biosystems's D&A?: Over 4 years (2021 to 2025), Rapid Micro Biosystems's D&A has grown at a 21.5% compound annual growth rate (CAGR), from $1.49M to $3.25M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.